Russo D; Martinelli G; Malagola M; Skert C; Soverini S; Iacobucci I; De Vivo A; Testoni N; Castagnetti F; Gugliotta G; Turri D; Bergamaschi M; Pregno P; Pungolino E; Stagno F; Breccia M; Martino B; Intermesoli T; Fava C; Abruzzese E; Tiribelli M; Bigazzi C; Cesana BM; Rosti G; Baccarani M., Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia., «BLOOD», 2013, 121, pp. 5138 - 5144 [articolo]
Baccarani M; Deininger MW; Rosti G; Hochhaus A; Soverini S; Apperley JF; Cervantes F; Clark RE; Cortes JE; Guilhot F; Hjorth-Hansen H; Hughes TP; Kantarjian HM; Kim DW; Larson RA; Lipton JH; Mahon FX; Martinelli G; Mayer J; Müller MC; Niederwieser D; Pane F; Radich JP; Rousselot P; Saglio G; Saußele S; Schiffer C; Silver R; Simonsson B; Steegmann JL; Goldman JM; Hehlmann R., European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013., «BLOOD», 2013, 122, pp. 872 - 884 [articolo]
De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F,Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, Bochicchio MT, Cattina F, Mancini M, Leo E, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G, High frequency of small insertions and deletions in the BCR-ABL Kinase Domain revealed by ultra-deep sequencing, «HAEMATOLOGICA», 2013, 98, pp. 128 - 128 [abstract]
Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli, Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain, «BLOOD», 2013, 122, pp. 3986 - 3986 [abstract]
Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli, Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain, «BLOOD», 2013, 122, pp. 3986 - 3986 [abstract]
Cristina Papayannidis, Caterina De Benedittis, Simona Soverini, Ilaria Iacobucci, Maria Chiara Abbenante, Chiara Sartor, Maria Teresa Bochicchio, Anna Ferrari, Claudia Venturi, Valentina Robustelli, Andrea Ghelli Luserna Di Rorà, Viviana Guadagnuolo, Emanuela Ottaviani, Nicoletta Testoni, Carmen Baldazzi, Simona Luatti, Sarah Parisi, Stefania Paolini, Cristina Clissa, Alberto Conficoni, Federica Frabetti, Elisa Lani, Silvia Piccari, Paolo Di Bartolomeo, Roberto Di Lorenzo, Renato Fanin, Giuseppe Cimino, Giovanni Martinelli, Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience, «BLOOD», 2013, 122, pp. 3911 - 3911 [abstract]
Stein AM; Martinelli G; Hughes TP; Müller MC; Beppu L; Gottardi E; Branford S; Soverini S; Woodman RC; Hochhaus A; Kim DW; Saglio G; Radich JP., Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia, «BMC CANCER», 2013, 13, pp. 173 - 182 [articolo]Open Access
Nicolini FE; Ibrahim AR; Soverini S; Martinelli G; Müller MC; Hochhaus A; Dufva IH; Kim DW; Cortes J; Mauro MJ; Chuah C; Labussière H; Morisset S; Roche-Lestienne C; Lippert E; Hayette S; Peter S; Zhou W; Maguer-Satta V; Michallet M; Goldman J; Apperley JF; Mahon FX; Marin D; Etienne G., The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis., «HAEMATOLOGICA», 2013, 98, pp. 1510 - 1516 [articolo]
Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Ilaria Iacobucci, Claudia Venturi, Manuela Mancini, Elisa Leo, Hana Klamova, Stefania Paolini, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli, Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy, «BLOOD», 2013, 122, pp. 380 - 380 [abstract]
Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G., Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain., «BLOOD», 2013, 122, pp. 1634 - 1648 [articolo]
Soverini S; Martinelli G.; Rosti G.; Iacobucci I.; Baccarani M., Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis, «PHARMACOGENOMICS», 2012, 13, pp. 1271 - 1284 [articolo]
Concetta Quintarelli; Biagio De Angelis; Santa Errichiello; Simona Caruso; Nicola Esposito; Luigia Luciano; Simona Paratore; Claudia Galimberti; Simona Soverini; Carolina Terragna; Daniela Cilloni; Giuseppe Saglio; Giovanni Martinelli; Frank Giles; Andreas Hochhaus; Fabrizio Pane, Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib, in: Blood, «BLOOD», 2012, 120(21), pp. 2795 - 2795 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Iacobucci I.; Ferrarini A.; Sazzini M.; Giacomelli E.; Lonetti A.; Xumerle L.; Ferrari A.; Papayannidis C.; Malerba G.; Luiselli D.; Boattini A.; Garagnani P.; Vitale A.; Soverini S.; Pane F.; Baccarani M.; Delledonne M.; Martinelli G., Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia, «BLOOD CANCER JOURNAL», 2012, 2, Article number: e61, pp. 1 - 7 [articolo]Open Access
SOVERINI S.; GNANI A.; CATERINA DE BENEDITTIS C.; IACOBUCCI I.; VENTURI C.; PAPAYANNIDIS C.; LUPPI M.; MERANTE S.; MALAGOLA M.; RUSSO D.; TIRIBELLI M.; SALVUCCI M.; VITALE A.; ELIA L.; VIGNETTI M.; FOÀ R.; BACCARANI M.; MARTINELLI G., Bcr-Abl kinase domain mutations and resistance in Ph+ acute lymphoblastic leukemia from the imatinib to the 2nd-generation TKI era, in: JCO, «JOURNAL OF CLINICAL ONCOLOGY», 2012, 30(15), pp. 6531 - 6531 (atti di: 2012 ASCO Annual Meeting, Chicago, IL, June 1-5, 2012) [atti di convegno-abstract]
Abate F.; Acquaviva A.; Paciello G.; Foti C.; Ficarra E.; Ferrarini A.; Delledonne M.; Iacobucci I.; Soverini S.; Martinelli G.; Macii E., Bellerophontes: an RNA-Seq data analysis framework for chimeric transcripts discovery based on accurate fusion model, «BIOINFORMATICS», 2012, 28, pp. 2114 - 2121 [articolo]
